Delivery Order SPE2DB22D2009-SPE2DB24FL9DA
Award Date
4/12/24
Potential Completion Date
4/15/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $4,826.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 5, 2024. The order is for 4,564,817,276 units of the BREYNA 160-4.5 MCG INHALER 10.3GM pharmaceutical product, with a completion date of June 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM. The contract, valued at $10,986.94, has an ultimate completion date of July 15, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $1,113.36 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a specific medical inhaler product, BREYNA 160-4.5 MCG INHALER 10.3GM, with a period of performance running through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of a pharmaceutical product, specifically the BREYNA 160-4.5 MCG INHALER 10.3GM, at a firm fixed price of $17,991.07. The contract is set to expire on September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 160-4.5 MCG INHALER 10.3GM medication. The contract has a firm fixed price of $2,428.87 and an ultimate completion date of September 20, 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,694.03, is for the procurement of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The $56,325.38 firm fixed-price contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024 and was awarded on September 27, 2024. There was no set-aside designation for this contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,163.97, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, to support military healthcare programs. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price delivery order. There is no set-aside...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,966,027 units of the BREYNA 160-4.5 MCG INHALER 10.3GM pharmaceutical product. The contract has a ceiling value of $4,405.77 and was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 21, 2024 with a completion date of June 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,951.88 firm fixed-price contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a prescription pharmaceutical product, with a completion date of April 22, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical,...